landiolol has been researched along with Cardiovascular Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Birkenhäger, TK; Boere, E; Groenland, TH; van den Broek, WW | 1 |
| Hirata, N; Miyashita, R; Watanabe, A; Yamakage, M | 1 |
1 review(s) available for landiolol and Cardiovascular Diseases
| Article | Year |
|---|---|
Beta-blocking agents during electroconvulsive therapy: a review.
Topics: Adrenergic beta-Antagonists; Cardiovascular Diseases; Electroconvulsive Therapy; Humans; Labetalol; Morpholines; Propanolamines; Randomized Controlled Trials as Topic; Urea | 2014 |
1 trial(s) available for landiolol and Cardiovascular Diseases
| Article | Year |
|---|---|
Low-dose continuous infusion of landiolol can reduce adrenergic response during tracheal intubation in elderly patients with cardiovascular disease.
Topics: Adrenergic beta-Antagonists; Aged; Anesthesia, General; Autonomic Nervous System Diseases; Blood Pressure; Cardiovascular Diseases; Female; Heart Rate; Hemodynamics; Humans; Infusions, Intravenous; Intubation, Intratracheal; Male; Morpholines; Oxygen; Urea | 2010 |